ACOR Notícias Forex
Acorda Withdraws Proposal To Raise Authorized Shares From Special Meeting Of Stockholders
Acorda Therapeutics, Inc. (ACOR) announced Monday that it has withdrawn Proposal One, a request to increase the number of authorized shares of Acorda stock, from the ballot for the Special Meeting of Stockholders scheduled for November 4, 2022.
RTTNews
|
822 dias atrás
Acorda Therapeutics COO Lauren Sabella To Resign
Biotechnology company Acorda Therapeutics, Inc. (ACOR) announced Friday that Lauren Sabella, Chief Operating Officer, will resign from the Company effective September 30, 2022. She will be working in a strategic advisory role for early-stage biotechnology companies.
RTTNews
|
874 dias atrás
